SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs12956780 | chr18:74792062 (GRCh38.p7) | G>A | alcohol dependence | SNV(Single Nucleotide Variation) |
rs7229235 | chr18:74783036 (GRCh38.p7) | G>A | alcohol dependence | SNV(Single Nucleotide Variation) |
rs1974956 | chr18:74782885 (GRCh38.p7) | G>A | alcohol dependence | SNV(Single Nucleotide Variation) |
rs7228438 | chr18:74781358 (GRCh38.p7) | G>T | alcohol dependence | SNV(Single Nucleotide Variation) |
rs7228254 | chr18:74781205 (GRCh38.p7) | G>C | alcohol dependence | SNV(Single Nucleotide Variation) |
rs9947276 | chr18:74780733 (GRCh38.p7) | A>T | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
HERC2 | 0.909 |
GLYR1 | 0.897 |
DNAJC11 | 0.894 |
LDB1 | 0.889 |
BOD1L1 | 0.888 |
ASH1L | 0.881 |
PRKDC | 0.878 |
MTOR | 0.875 |
MAN2A2 | 0.874 |
RALGAPB | 0.873 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
OR4F5 | -0.446 |
OR4F29 | -0.414 |
CSAG1 | -0.404 |
RAB13 | -0.381 |
ZNF114 | -0.376 |
FAM89A | -0.371 |
FMO3 | -0.355 |
COPZ2 | -0.354 |
MYL3 | -0.354 |
MTRNR2L6 | -0.351 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ZNF407 mRNA | 20106945|2163298 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of ZNF407 mRNA" | 20382639 |
D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ZNF407 mRNA" | 19150397 |
C044887 | beta-methylcholine | beta-methylcholine affects the expression of ZNF407 mRNA | 21179406 |
C006780 | bisphenol A | bisphenol A affects the expression of ZNF407 mRNA | 25181051 |
D019327 | Copper Sulfate | Copper Sulfate results in increased expression of ZNF407 mRNA | 19549813 |
D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of ZNF407 mRNA] | 27941970 |
D002945 | Cisplatin | Cisplatin results in decreased expression of ZNF407 mRNA | 27594783 |
D008727 | Methotrexate | Methotrexate results in increased expression of ZNF407 mRNA | 24449571 |
C568376 | MT19c compound | MT19c compound results in increased expression of ZNF407 mRNA | 21781307 |
C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of ZNF407 mRNA" | 26179874 |
D014635 | Valproic Acid | Valproic Acid affects the expression of ZNF407 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of ZNF407 mRNA | 24935251 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding | - | ISA | - |
GO:0003677 | DNA binding | - | IEA | - |
GO:0008270 | zinc ion binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0006351 | transcription, DNA-templated | - | IEA | - |
GO:0006357 | regulation of transcription by RNA polymerase II | - | IEA | - |
GO:0010468 | regulation of gene expression | - | IBA | 21873635 |
GO:0016569 | covalent chromatin modification | - | IBA | 21873635 |
GO:0031060 | regulation of histone methylation | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005634 | nucleus | COLOCALIZES_WITH | IBA | 21873635 |
GO:0005634 | nucleus | - | IEA | - |
GO:0035097 | histone methyltransferase complex | COLOCALIZES_WITH | IBA | 21873635 |
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|
PMID | Title (Year) | Author | Journal |
---|